PHAT

PHAT Operating Expenses

$239.37MTTM · USD

Period ending:

PHAT FY Operating ExpensesUSD
PHAT FY Operating Expenses2018-12-31: $1.23M2019-12-31: $106.22M2020-12-31: $125.37M2021-12-31: $134.56M2022-12-31: $171.82M2023-12-31: $167.83M2024-12-31: $324.75M2025-12-31: $312.50M$324.75M$0.00
2018-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

PHAT operating expenses history

Expenses from normal business operations (SG&A, R&D, etc.). The available annual fiscal periods series contains 8 observations from Dec 31, 2018 to Dec 31, 2025.

Phathom Pharmaceuticals Inc Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
312,497,000
324,746,000
167,827,000
171,820,000
134,559,000
125,365,000
106,215,000
1,225,000

Compare operating expenses

All PHAT financial metrics · PHAT stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.